About BeiGene
Perspectives from our leadership
Partner With Us
Video
Joshua Neiman
SVP, Chief Commercial Officer,
North America and Europe
BeiGene
Why Engage?
Video
Jay Seemann
Vice President, Market Access
BeiGene
Our perspective on pricing & value
We believe in:
- Striving to lower the total cost of care
- Pricing our products to provide maximum value vs in-class competitors
- Lowering out-of-pocket costs for patients
Our value story begins with the clinical utility of our products. This value is created in the lab, substantiated in pivotal trials, and validated in the real world. It’s supported both by credible health economics data and by BeiGene’s continued commitment to innovation in oncology.
Investigative product portfolio
We are pursuing a broad and deep pipeline with the potential to address the vast majority of the world’s cancers. In addition to leveraging our internal research resources, we continually evaluate external preclinical and early-stage assets that might expand our pipeline and contribute to our durable competitive advantages.